Arlington, MA, United States of America

Dinesh U Chimmanamada

This inventor holds 46 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 11 EPO patents, primarily in Targeted Therapeutics. Top assignees: Synta Pharmaceuticals Corporation, Madrigal Pharmaceuticals, Inc., Berg LLC. Active years: 2009-2022.

USPTO Granted Patents = 46 

% Patents Active = 60.9

 

 

Average Co-Inventor Count = 4.8

ph-index = 17

Forward Citations = 700(Granted Patents)


Location History:

  • Waltham, MA (US) (2009 - 2015)
  • Arlington, IN (2015)
  • Arlington, MA (US) (2012 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Targeted Therapeutics
HSP90 Modulators
Triazole Compounds
Pyrrole Compounds
Inflammation Treatments
UBE2K Modulators
Combination Therapies
Hydrazonamide Compounds
IL-12 Modulatory Compounds
Fused Heterocyclic Compounds
46 patents (USPTO):Explore Patents

Title: Dinesh U Chimmanamada: A Pioneer in Targeted Therapeutics

Introduction

Dinesh U Chimmanamada, based in Arlington, MA, is a notable inventor with an impressive portfolio of 46 patents. His work primarily focuses on pharmacological innovations, particularly in the field of targeted therapeutics. His inventions aim to improve the efficacy of treatments, especially in the management of cancer.

Latest Patents

Among his most recent patents, Chimmanamada has developed therapies that encompass pharmacological compounds featuring an effector moiety conjugated to a binding moiety. These compounds direct the effector moiety toward specific biological targets. His inventions also include various compositions, kits, and methodologies applicable in therapeutic, diagnostic, and imaging contexts. A standout innovation is the protein interacting binding moiety-drug conjugate (SDC-TRAP) approach, particularly in cancer treatment, where a Heat Shock Protein 90 (Hsp90) inhibitor is conjugated to a cytotoxic agent.

Career Highlights

Throughout his career, Dinesh U Chimmanamada has contributed substantially to pharmaceutical advancements while working at prominent companies such as Synta Pharmaceuticals Corporation and Madrigal Pharmaceuticals, Inc. His innovations have had a significant impact on the development of treatments that leverage targeted pharmacological strategies.

Collaborations

Chimmanamada has collaborated with various experts in his field, including notable coworkers such as Weiwen Ying and Shijie Zhang. These collaborations have likely enhanced the depth and breadth of his research and the effectiveness of his patented inventions.

Conclusion

Dinesh U Chimmanamada's contributions to the field of targeted therapeutics showcase his dedication to advancing medical science through innovation. His impressive record of patents reflects his commitment to improving treatment options, especially for cancer patients, underscoring his role as a significant influencer in the realm of pharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…